Signal-regulatory protein alpha, which has recently attracted attention as a candidate target of immune checkpoint inhibitors in the field of cancer (45–48), was highly expressed on neutrophils, monocytes, and macrophages in the Burn/CLP group. The gene discussed is SIRPA; the disease is cancer.